Home / Recalls / Medical Devices
Cytocell Ltd. recalls TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequenc
Recalled March 30, 2022 · FDA recall Z-0814-2022 · Cytocell
Hazard
May show unexpected locus specific signals in addition to those at 14q32. · FDA Class III
Units
1 unit
Sold at
MN
Description
May show unexpected locus specific signals in addition to those at 14q32.
Product
TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A
Manufacturer(s)
Cytocell Ltd.
Made in
United Kingdom
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →